250 related articles for article (PubMed ID: 10837965)
1. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
[TBL] [Abstract][Full Text] [Related]
2. Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.
Braakhuis BJ; van Dongen GA; Vermorken JB; Snow GB
Cancer Res; 1991 Jan; 51(1):211-4. PubMed ID: 1988086
[TBL] [Abstract][Full Text] [Related]
3. The role of cell cycle progression in radiosensitization by 2',2'-difluoro-2'-deoxycytidine.
Ostruszka LJ; Shewach DS
Cancer Res; 2000 Nov; 60(21):6080-8. PubMed ID: 11085531
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model.
Joschko MA; Webster LK; Groves J; Yuen K; Palatsides M; Ball DL; Millward MJ
Radiat Oncol Investig; 1997; 5(2):62-71. PubMed ID: 9303059
[TBL] [Abstract][Full Text] [Related]
5. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.
Eisbruch A; Shewach DS; Bradford CR; Littles JF; Teknos TN; Chepeha DB; Marentette LJ; Terrell JE; Hogikyan ND; Dawson LA; Urba S; Wolf GT; Lawrence TS
J Clin Oncol; 2001 Feb; 19(3):792-9. PubMed ID: 11157033
[TBL] [Abstract][Full Text] [Related]
6. The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.
Lawrence TS; Davis MA; Hough A; Rehemtulla A
Clin Cancer Res; 2001 Feb; 7(2):314-9. PubMed ID: 11234886
[TBL] [Abstract][Full Text] [Related]
7. Maximizing therapeutic gain with gemcitabine and fractionated radiation.
Mason KA; Milas L; Hunter NR; Elshaikh M; Buchmiller L; Kishi K; Hittelman K; Ang KK
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1125-35. PubMed ID: 10421547
[TBL] [Abstract][Full Text] [Related]
8. Enhanced radiosensitization with gemcitabine in mismatch repair-deficient HCT116 cells.
Robinson BW; Im MM; Ljungman M; Praz F; Shewach DS
Cancer Res; 2003 Oct; 63(20):6935-41. PubMed ID: 14583494
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.
Shewach DS; Hahn TM; Chang E; Hertel LW; Lawrence TS
Cancer Res; 1994 Jun; 54(12):3218-23. PubMed ID: 8205542
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
Zwitter M; Kovac V; Smrdel U; Strojan P
J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine as a radiosensitizer for nonresectable feline oral squamous cell carcinoma.
Jones PD; de Lorimier LP; Kitchell BE; Losonsky JM
J Am Anim Hosp Assoc; 2003; 39(5):463-7. PubMed ID: 14518654
[TBL] [Abstract][Full Text] [Related]
12. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine).
Lawrence TS; Chang EY; Hahn TM; Shewach DS
Clin Cancer Res; 1997 May; 3(5):777-82. PubMed ID: 9815749
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial.
Hoffmann W; Belka C; Schmidberger H; Budach W; Bochtler H; Hess CF; Bamberg M
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):691-6. PubMed ID: 9240634
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
Lawrence TS; Chang EY; Hahn TM; Hertel LW; Shewach DS
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):867-72. PubMed ID: 8598364
[TBL] [Abstract][Full Text] [Related]
15. Schedule-dependent antitumor effect of gemcitabine in in vivo model system.
Braakhuis BJ; Ruiz van Haperen VW; Boven E; Veerman G; Peters GJ
Semin Oncol; 1995 Aug; 22(4 Suppl 11):42-6. PubMed ID: 7481844
[TBL] [Abstract][Full Text] [Related]
16. Late DNA Damage Mediated by Homologous Recombination Repair Results in Radiosensitization with Gemcitabine.
Im MM; Flanagan SA; Ackroyd JJ; Knapp B; Kramer A; Shewach DS
Radiat Res; 2016 Nov; 186(5):466-477. PubMed ID: 27740890
[TBL] [Abstract][Full Text] [Related]
17. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas.
Chauhan A; Singh H; Sharma T; Manocha KK
Afr Health Sci; 2008 Sep; 8(3):149-55. PubMed ID: 19357741
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breast carcinoma cell lines.
Robinson BW; Shewach DS
Clin Cancer Res; 2001 Aug; 7(8):2581-9. PubMed ID: 11489842
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine in advanced pancreatic cancer.
Yavuz AA; Aydin F; Yavuz MN; Ilis E; Ozdemir F
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):974-81. PubMed ID: 11704320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]